Learning and Memory Learning deficiencies and Disorders

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Richard P. Halgin Susan Krauss Whitbourne University of Massachusetts at Amherst slides by Travis Langley Henderson State University Abnormal Psychology.
Dementia Drugs: Mainstream and Alternative Medicines Susan Kurrle.
NHPA’s Chapter 3. National Health Priority Areas A collaborative initiative endorsed by the Commonwealth and all state and territory governments, which.
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
Cognitive Enhancers. Dementia A syndrome due to disease of the brain, characterised by progressive, global deterioration in intellect including: Memory.
CHAPTER 12 Learning and Memory Learning deficiencies, dementias and Intellectual Disorders.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
And Alzheimer’s Disease
Chapter 9: The Biology of Learning and Memory. Basic History of Learning & Memory  There are 3 people I want you to know: 1. Pavolv 2. Skinner 3. Lashley.
Chapter 15 - Cognitive Disorders I.Delirium Acute, temporary impairment in perception & cognition Fluctuating course.
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Alzheimer’s Disease Angela Singh, PharmD Associate Professor of Pharmacy Practice Florida A&M University College of Pharmacy & Pharmaceutical Sciences.
ALZHEIMER’S PART 2. AD VIDEO
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 14 Cognitive Disorders and Life-Span Issues.
LISA JOHNSON & SUZANNE GRIESEL MPH 543 LEADERSHIP AND ORGANIZATIONAL BEHAVIOR FEBRUARY 16, 2014 Funding Analysis of Alzheimer’s Treatment Options: Three.
By: Tasso Skountzouris David Schiano. General Description  Alzheimer’s is one the most common form of Dementia  Dementia causes a loss of brain function.
Alzheimer’s Disease Causes, Effects, and Treatments.
Memory Disorders Psychology Introduction The strange case of Charles D’Sousa Or is it Philip Cutajar? Rare type of disorder Some stuff clearly spared.
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
CONFUSION & DEMENTIA CHAPTER 35.
Cognitive Disorders Chapter 15. Defined as when a human being can no longer understand facts or connect the appropriate feelings to events, they have.
ALZHEIMER’S WHAT IS IT – WHAT TO DO ABOUT IT. VIDEO
Amyotrophic lateral sclerosis
Dementia Care Wendy Burnett CNS for Older People.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Dementia Nicholas Cascone, PA-C.
** In this project I also refer to Alzheimer’s as Dementia and AD**
Alzheimer’s disease.
BY: AMAN SINGH AND ALLY MATTINGLY Alzheimer's Disease.
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
It is a chronic neurodegenerating disease that usually starts slowly and gets worse over time.
CHAPTER 12 Learning and Memory Learning deficiencies and Disorders.
Orientation to Early Memory Loss. Let’s look for some answers… What is happening? What should I do? Where should I go?
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Anne Moore Specialist in Special Care NHS Lanarkshire PDS
Master’s Advanced Curriculum (MAC) Teaching Module: Advanced Practice in Mental Health Settings Acknowledgement: The development of this PowerPoint was.
DEMENTIA Shenae Whitfield & Kate Maddock.
Memory Deficiency & Memory
Memory Deficiency & Memory
Chapter 14 Neurocognitive Disorders
Chapter Thirteen The Biology of Learning and Memory
Chapter 13 Learning and Memory
Neurocognitive Disorders
Unit 40 Dementia care.
Medications for Dementia
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
Amnesia Syndromes Lecture 21.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Progress Report on Alzheimer’s Disease
Limbic system.
Chapter 30 Delirium and Dementia
Diagnosing Patient #2 The two studs (you know who we are) (Zach and Jack in case you didn’t know)
Diagnosing Patient #2 The two studs (you know who we are) (Zach and Jack in case you didn’t know)
Drugs for Degenerative Diseases of the Nervous System
Alzheimer's.
Learning and Memory Chapter 12
Neurotransmitters and the Synapse
Chapter 25 The Elderly.
thinking about learning and memory
Relational Learning and Amnesia
Presentation transcript:

Learning and Memory Learning deficiencies and Disorders CHAPTER 12 Learning and Memory Learning deficiencies and Disorders

Dementia

Memory loss and aging For many years researchers believed: deficits in the elderly caused by a substantial loss of neurons Loss was especially from the cortex and the hippocampus. More recent investigations number of hippocampal neurons not diminished in aged rats Even rats with memory deficits show little neuronal loss What neuronal loss occurs from cortical areas was relatively minor. BUT: certain circuits in the hippocampus do lose synapses and NMDA receptors as animals age. Probably as a result of these changes, LTP is impaired in aged rats.

dementias Dementia Other dementias: substantial loss of memory and other cognitive abilities Typically in elderly 50% of those over 80 show some signs of dementia Other dementias: Frontal-temporal dementia Vascular dementias Dementias from illness such as stroke/heart attack

dementias most common cause of dementia is Alzheimer’s disease most common cause of dementia is progressive brain deterioration, impaired memory, loss of other mental abilities. Earliest and most severe symptom = impaired declarative memory. Language, visual-spatial functioning, and reasoning are particularly affected Behavioral problems such as aggressiveness and wandering away from home.

dementias Sundowning: Increased confusion and restlessness in patients Behavioral problems begin to occur in the evening or while the sun is setting. More frequent during the middle stages of Alzheimer's disease and mixed dementia. Subsides with the progression of dementia. 20–45% of Alzheimer's patients will experience some sort of sundowning confusion. Alzheimer’s affects nearly 10% of people over 65 years of age, and nearly half of those over 85.

http://www.youtube.com/watch?v=MUCO1h48AHM&feature=related

Brain changes in dementia There are two notable characteristics of the Alzheimer’s brain, though they are not unique to the disease. Plaques Neurofibrillary tangles Plaques = clumps of amyloid a type of protein cluster among axon terminals interfere with neural transmission. Abnormal accumulations of the protein tau form inside neurons. Tangles are associated with the death of brain cells.

Figure 12.14 Neural abnormalities in the brain of an Alzheimer’s patient (a) The round clumps in the photo are plaques. (b) The dark twisted features are neurofibrillary tangles. Figure 12.14 Neural abnormalities in the brain of an Alzheimer’s patient (a) The round clumps in the photo are plaques. (b) The dark twisted features are neurofibrillary tangles.

Dementia brain changes In the Alzheimer’s brain, Gyri are smaller Sulci are wider than in the normal brain. In the diseased brain, many of the lesions are located in the temporal lobe. Because of their location, they effectively isolate the hippocampus from its inputs and outputs, This partially explains the early memory loss. Plaques and tangles in the frontal lobes account for Additional memory problems Attention and motor difficulties.

Figure 12.15 Alzheimer’s brain (left) and a normal brain The illustrations show the most obvious differences, the reduced size of gyri and increased size of sulci produced by cell loss in the diseased brain. Figure 12.15 Alzheimer’s brain (left) and a normal brain The illustrations show the most obvious differences, the reduced size of gyri and increased size of sulci produced by cell loss in the diseased brain.

Ach and memory Acetylcholine: Neural systems in various parts of the brain that produce acetylcholine are critical for cognitive functions including attention and learning. Acetylcholine-releasing neurons are among the victims of degeneration in Alzheimer’s disease. The majority of treatment efforts have focused on restoring acetylcholine functioning. E.g., cognex, aricept, exelon

Drugs for dementia Currently five drugs approved by the FDA for the treatment of Alzheimer’s. Four of them improve acetylcholine neurotransmission by preventing the breakdown of acetylcholine at the synapses (AchE inhibitors). Drugs provide only modest relief for both memory and behavioral symptoms in mild cases of Alzheimer’s Little or no help when degeneration is advanced.

Drugs for dementia Generic Brand Approved For Side Effects donepezil Aricept All stages Nausea, vomiting, loss of appetite and increased frequency of bowel movements. galantamine Razadyne Mild to moderate memantine Namenda Moderate to severe Headache, constipation, confusion and dizziness. rivastigmine Exelon memantine + donepezil Namzaric Headache, diarrhea, dizziness, loss of appetite, vomiting, nausea, and bruising.

Drugs for dementia Other drug treatment Psychotropic drugs to control behavioral symptoms, reduce hallucinations Haldol, serentil, seroquel, respiridone, mellaril Antiseizure medications to control onset of seizures Gabapentin (neurotin), dilantin, tegretol Tranqulizers and antidepressants Ativan, valium, xanax, Wellbutrin, lexapro Side-effects May make lethargic May make memory loss greater May speed up death

Newer dementia drug Memantine: first approved for use in patients with moderate and severe symptoms. Some neuron loss in Alzheimer’s occurs when dying neurons trigger the release of the excitatory transmitter glutamate. The excess glutamate overstimulates NMDA receptors and kills neurons, a phenomenon known as excitotoxicity. Memantine limits the neuron’s sensitivity to glutamate, reducing further cell death. Studies indicate moderate slowing of deterioration and improvement in symptoms.

Korsakoff’s syndrome Korsakoff’s syndrome Another form of dementia is, brain deterioration Almost always caused by chronic alcoholism. Typically affects people in 50’s and 60’s With heavy binge drinking, onset earlier: 20’s and 30’s

Korsakoff’s syndrome The deterioration results from a deficiency in the vitamin thiamine (B1), which has two causes: The alcoholic consumes large quantities of calories in the form of alcohol in place of an adequate diet. The alcohol reduces absorption of thiamine in the stomach.

Korsakoff’s syndrome The most pronounced symptom : anterograde amnesia Retrograde amnesia is also severe. Impairment is to declarative memory, while nondeclarative memory remains intact. Several brain changes: Hippocampus and temporal lobes are unaffected. Mammillary bodies and the medial part of the thalamus are reduced in size Structural and functional abnormalities occur in the frontal lobes. Thiamine therapy can relieve the symptoms if the disorder is not too advanced, Brain damage itself it irreversible.

Korsakoff’s symptoms Confabulation Confabulation : Some Korsakoff’s patients show a particularly interesting characteristic in their behavior Many other dementia patients, particularly frontal-temporal lobe also show this They fabricate stories and facts to make up for those missing from their memories. Confabulation : Depends on abnormal activity in the frontal lobes Confabulating patients usually have lesions there.

Korsakoff’s symptoms Confabulating amnesic patients More trouble than nonconfabulating amnesiacs in suppressing irrelevant information they have learned earlier. Why? confabulation is due to an inability to distinguish between current reality and earlier memories. NOT that they are lying, but that they are unable to tell the difference between real memories and their confabulation No amount of arguing will tell them that they are wrong, because they have a “memory” of it. It is as real as any other memory

Korsakoff’s symptoms http://www.youtube.com/watch?v=wDcyBXJAZNM

Eloquent Description of Dementia Dementia is like opening a book of someone’s life and randomly ripping individual pages out, one by one, until there is nothing left but the cover. Simon Weisenthal